Search
Displaying results 2861 - 2870 of 10000 in total
Squamous Cell Cancer Non-Small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0059210Drugs: TislelizumabSynonyms: Lung Non-Small Cell Squamous Carcinoma, Non-Small Cell Squamous Lung CancerStage IIIA Non-Small Cell Lung Cancer (NSCLC)
go.drugbank.com/conditions/DBCOND0173421Drugs: PembrolizumabSynonyms: Stage IIIA Non-Small Cell Lung Cancer (NSCLC)Stage IV Non-small Cell Lung Cancer (NSCLC)
go.drugbank.com/conditions/DBCOND0122752Drugs: GemcitabineSynonyms: Non-Small Cell Lung Cancer Stage IV, Stage 4 Non-small cell lung cancerLocally advanced Non-Small Cell Lung Carcinoma (NSCLC)
go.drugbank.com/conditions/DBCOND0145709Drugs: NintedanibSynonyms: Locally advanced Non-Small Cell Lung Carcinoma (NSCLC)Locally advanced nonsquamous non-small cell lung cancer
go.drugbank.com/conditions/DBCOND0022054Synonyms: Locally advanced Non-Squamous Non-Small Cell Lung Cancer, Locally advanced Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Locally advanced untreated non small cell lung cancer
go.drugbank.com/conditions/DBCOND0025494Drugs: DocetaxelSynonyms: Locally advanced untreated non small cell lung cancer, Locally advanced Untreated Non-Small Cell Lung CancerNon-purulent ophthalmic infections caused by susceptible bacteria
go.drugbank.com/conditions/DBCOND0135837Drugs: ChloramphenicolSynonyms: Non-purulent ophthalmic infections caused by susceptible bacteriaStage 2 Non-Small Cell Lung Cancer (NSCLC)
go.drugbank.com/conditions/DBCOND0173420Drugs: PembrolizumabSynonyms: Stage 2 Non-Small Cell Lung Cancer (NSCLC)Vepdegestrant
go.drugbank.com/drugs/DB19006ApprovedInvestigational[A275508, A275509] On May 1, 2026, the FDA granted approval for vepdegestrant tablets under the trade name VEPPANU.
Vatalanib
go.drugbank.com/drugs/DB04879InvestigationalVatalanib (PTK787/ZK-222584) is a new oral antiangiogenic molecule that inhibits all known vascular endothelial growth factor receptors.